Gomiero Mirella Basolli Sells 10,000 Shares of Afya (NASDAQ:AFYA) Stock

Afya Limited (NASDAQ:AFYA) VP Gomiero Mirella Basolli sold 10,000 shares of the company’s stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $14.80, for a total value of $148,000.00. Following the completion of the transaction, the vice president owned 34,530 shares of the company’s stock, valued at $511,044. The trade was a 22.46% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Afya Price Performance

Shares of Afya stock traded down $0.03 during trading on Tuesday, hitting $14.84. 109,181 shares of the stock traded hands, compared to its average volume of 105,793. The stock has a market cap of $1.39 billion, a price-to-earnings ratio of 9.70, a PEG ratio of 1.53 and a beta of 0.34. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.42. Afya Limited has a 52 week low of $13.00 and a 52 week high of $18.16. The firm’s fifty day moving average is $14.33 and its 200-day moving average is $14.52.

Hedge Funds Weigh In On Afya

Large investors have recently bought and sold shares of the stock. Van ECK Associates Corp boosted its holdings in shares of Afya by 15.7% during the third quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock worth $159,000 after purchasing an additional 1,377 shares during the period. Daiwa Securities Group Inc. purchased a new position in Afya during the 4th quarter valued at about $43,000. Arrowstreet Capital Limited Partnership increased its holdings in Afya by 5.6% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 68,169 shares of the company’s stock valued at $1,217,000 after purchasing an additional 3,626 shares during the period. Militia Capital Partners LP bought a new position in Afya during the 2nd quarter valued at approximately $71,000. Finally, Fairtree Asset Management Pty Ltd raised its position in Afya by 22.3% during the 4th quarter. Fairtree Asset Management Pty Ltd now owns 30,697 shares of the company’s stock valued at $473,000 after purchasing an additional 5,599 shares during the last quarter. 88.02% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have commented on AFYA shares. Zacks Research downgraded shares of Afya from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, May 6th. Wall Street Zen cut shares of Afya from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 2nd. Bank of America reaffirmed a “neutral” rating on shares of Afya in a report on Thursday, June 11th. Weiss Ratings reiterated a “hold (c)” rating on shares of Afya in a research report on Monday, April 20th. Finally, JPMorgan Chase & Co. lowered their price target on shares of Afya from $21.50 to $21.00 and set a “neutral” rating for the company in a research note on Monday, June 22nd. One investment analyst has rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $17.10.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.